Amfonelic acid

Amfonelic acid
Systematic (IUPAC) name
1-ethyl-4-oxo-7-(phenylmethyl)-1,8-naphthyridine-3-carboxylic acid;
Clinical data
Pregnancy cat.  ?
Legal status Uncontrolled
Identifiers
CAS number 15180-02-6 Y
ATC code None
PubChem CID 2137
ChemSpider 2052 Y
UNII RR302AR19Y N
KEGG D02897 Y
ChEMBL CHEMBL35337 Y
Chemical data
Formula C18H16N2O3 
Mol. mass 308.331 g/mol
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Amfonelic acid (AFA; WIN 25,978; Oxaprozin) is a psychoactive drug and research chemical used in scientific studies. It was discovered while researchers were investigating novel antibiotics.[1] It acts as a potent and highly selective dopamine reuptake inhibitor (DRI).[2][3] It has a moderately long half-life of approximately 12 hours. It is currently being researched as a medication to offset the sedative side-effects and enhance the noiciceptive activity of strong opioid analgesics[4]

See also

References

  1. ^ US Patent 3590036 - Naphthyridine-3-carboxylic Acids, Their Derivatives and Preparation Thereof
  2. ^ Fuller RW, Perry KW, Bymaster FP, Wong DT. (1978). "Comparative effects of pemoline, amfonelic acid and amphetamine on dopamine uptake and release in vitro and on brain 3,4-dihydroxyphenylacetic acid concentration in spiperone-treated rats.". J Pharm Pharmacol. 30 (3): 197–198. PMID 24701. 
  3. ^ McMillen BA, Shore PA. (1978). "Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems.". J Pharm Pharmacol. 30 (7): 464–466. PMID 27622. 
  4. ^ WO Patent 2005/107467(A2) - COMPOSITIONS INCLUDING OPIOIDS AND METHODS OF THEIR USE IN TREATING PAIN